Retatrutide Dosage: What the Studies Used
What Retatrutide amounts the studies tested
A small early study and Phase 2 studies tested 0.5 mg through 12 mg. Study staff gave one weekly shot beneath the skin. Those numbers name the study groups. They aren't an approved amount for you.
Retatrutide isn't an approved drug. Retatrutide has no FDA-approved label or prescribing dose. The drug has a 6-day half-life. That timing helped set the weekly study shots. Half-life tells when blood has lost half.
This page lists each studied amount. Later parts explain what happened when the amount rose. They also explain why outside powder has no approved mixing or storage plan.
Phase 2 and Phase 3 studies gave Retatrutide under the skin once each week. The first was an earlier mid-stage test. The second was a larger late test. Study staff raised the amount in set steps.
The medicine stayed in the bloodstream for several days. Lab reports also describe test liquids and storage. None of those facts creates an approved amount for you outside a study.
What the Phase 2 and Phase 3 study groups received
The Phase 2 weight study tested 1 mg, 4 mg, 8 mg, and 12 mg each week. The first amount was 2 mg. It rose every 4 weeks until the set amount [1].
For type 2 diabetes, the Phase 2 study tested 0.5 mg, 4 mg, 8 mg, and 12 mg. A dulaglutide 1.5 mg group supplied another check [2].
The Phase 3 TRIUMPH-1 study tested 4 mg, 9 mg, and 12 mg. Study staff gave a weekly shot beneath the skin. Its 80-week check supplied the result [5].
TRIUMPH-4 was a Phase 3 study of 9 mg and 12 mg each week. Its 68-week check covered adults with obesity and knee arthritis [8].
The largest amount studied was 12 mg each week. No daily form has been studied. A 6-day half-life fits the weekly timing [19]. Half-life tells when blood has lost half.
How the Phase 3 Retatrutide studies raised the amount
TRIUMPH Phase 3 studies began with 2.5 mg beneath the skin each week. That lasted through weeks 1–4. The amount then rose by 2.5 mg every 4 weeks.
The top set amount was 12 mg per week [5]. Phase 2 used much the same steps. It moved from 2 mg to 4, 8, and 12 mg. Those were Phase 3 study steps, not a plan for you.
The slow rise was meant to ease stomach and bowel trouble. The worst nausea, vomiting, diarrhea, and constipation came in weeks 1–8. The problems often eased after the amount stayed level [10]. Phase 2 reports tied most trouble to the rise.
Across Phase 2, the range ran from 0.5 mg to 12 mg. Phase 3 set 12 mg as the top amount. Its lower TRIUMPH-1 group got 4 mg. None of these facts gives you a personal schedule.
What weekly Retatrutide amounts belonged to study groups
Phase 2 tested five weekly amounts under the skin. They were 0.5 mg, 1 mg, 4 mg, 8 mg, and 12 mg [1][2]. Only the diabetes study used the smallest amount.
Phase 3 groups got 4 mg, 9 mg, or 12 mg. No published study has reported more than 12 mg per week. Those study numbers don't pick your amount.
Study staff scheduled one shot per week. They used the belly, thigh, or upper arm in the studies. The written study plan governed every shot.
What the Retatrutide half-life means
In people, the Retatrutide half-life is about 6 days [19]. Half-life means blood takes about 6 days to lose half the drug. A small Phase 1 study found that timing.
Phase 2 groups then backed it up. Blood levels rose with the studied range of 1–12 mg. The term helps explain the weekly study schedule.
Two drug changes slow removal. A fatty attachment keeps the drug with a blood protein. Another change blocks a blood enzyme that quickly breaks down the matching natural hormone.
That hormone is called GLP-1. It helps control hunger and blood sugar. The natural hormone lasts about 2 minutes. Together, the drug changes stretch the half-life to about 6 days. The timing fits a weekly study shot beneath the skin.
Blood levels build slowly during that span. A level amount takes about 4–5 weeks, or 4–5 half-lives. At week 4, the blood level may still be building. Week 4 can still be too early for a level amount. The same delay follows a change in amount. Benefits and side effects may also lag. The main span stays close to that.
What may happen after Retatrutide stops
Follow-up from Phase 3 TRIUMPH is still under way. It hasn't shown how much weight returns after retatrutide stops. Related GLP-1 drugs, which copy one hunger hormone, often bring weight regain. That GLP-1 label covers several related drugs.
One review combined studies of people who stopped those drugs. Weight regain leveled near 75.6% of the loss. A 95% range showed that the true group figure could be lower or higher [18].
The drugs and follow-up times differed. Papers have proposed a slower stop and lasting daily habits [18]. Those ideas haven't been proved for retatrutide.
Later TRIUMPH reports may give a firmer answer. The drug has a 6-day half-life. Blood levels may become too low to find about 4–5 weeks after the last dose.
Why Retatrutide lab liquid is not a home recipe
Some labs receive freeze-dried retatrutide powder. Researchers add germ-free water before testing it. That lab step is called mixing the test sample.
One report says its test liquid held 1 mg in 1 mL. Those figures describe the sample used in that lab. They don't create a safe home mixing plan.
Lilly's study drug came ready mixed in auto-injector pens. People in those studies didn't mix it. Freeze-dried powder from outside suppliers hasn't had FDA checks for safety, effect, or germs.
Why outside Retatrutide powder has no mixing guide
Some labs use sterile water made to slow germ growth. Their written plans describe trained workers, clean rooms, and checks for damage. Those facts don't make a home process safe.
Lab workers inspect the finished test liquid for cloudiness or bits. A failed sample is discarded. A person at home can't copy the lab's germ checks.
Some reports describe test liquids from 1–2 mg/mL. Those are sample strengths, not personal amounts. Outside powder has no FDA check for its contents or germs.
What lab storage cannot prove about Retatrutide
Lab reports kept freeze-dried retatrutide powder at -20°C for long storage. Repeated freezing and thawing could harm the lab sample.
After researchers made a test liquid, they kept it at 2–8°C for 28–30 days. They didn't freeze the liquid and kept it away from light. Those facts describe lab plans, not an FDA label. They can't prove that outside powder is safe.